Ligand validation:4O81

AMP: ADENOSINE MONOPHOSPHATE

AMP is a Ligand Of Interest in 4O81 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4O81_AMP_B_312	65%	34%	0.134	0.935	1.02	1.57	2	4	0	0	100%	0.9
4O81_AMP_A_308	43%	44%	0.159	0.883	0.86	1.3	-	2	0	0	100%	0.8
4O81_AMP_A_309	42%	36%	0.201	0.923	1.07	1.44	2	3	0	0	100%	0.85
4O82_AMP_B_411	58%	37%	0.134	0.911	1.03	1.44	2	3	0	0	100%	1
4O83_AMP_A_310	27%	42%	0.183	0.829	0.91	1.35	1	2	0	0	100%	0.9
8YNQ_AMP_D_504	100%	43%	0.041	0.99	0.96	1.26	1	2	11	0	100%	1
3G89_AMP_B_304	100%	32%	0.038	0.986	1.05	1.63	1	4	6	0	100%	1
3LOQ_AMP_A_271	100%	45%	0.039	0.987	0.82	1.3	-	2	2	0	100%	1
7SNB_AMP_A_303	100%	55%	0.045	0.993	0.75	0.98	-	1	0	0	100%	0.78
3FWZ_AMP_B_601	100%	32%	0.037	0.984	1.15	1.55	2	4	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.